Loading...
Loading...
India's dapagliflozin imports from MALAYSIA total $64 across 2 shipments from 1 foreign suppliers. PROPHARMA REGULATORY SERVICES leads with $64 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include INVENTIA HEALTHCARE LIMITED. This corridor reflects India's pharmaceutical import demand for dapagliflozin โ a concentrated sourcing relationship with select suppliers from MALAYSIA.

PROPHARMA REGULATORY SERVICES is the leading Dapagliflozin supplier from MALAYSIA to India, with import value of $64 across 2 shipments. The top 5 suppliers โ PROPHARMA REGULATORY SERVICES โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PROPHARMA REGULATORY SERVICES | $64 | 2 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | INVENTIA HEALTHCARE LIMITED | $64 | 2 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Dapagliflozin suppliers from MALAYSIA to India include PROPHARMA REGULATORY SERVICES. The leading supplier is PROPHARMA REGULATORY SERVICES with import value of $64 USD across 2 shipments. India imported Dapagliflozin worth $64 USD from MALAYSIA in total across 2 shipments.
India imported Dapagliflozin worth $64 USD from MALAYSIA across 2 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Dapagliflozin sourced from MALAYSIA include INVENTIA HEALTHCARE LIMITED. The largest buyer is INVENTIA HEALTHCARE LIMITED with $64 in imports across 2 shipments.
The total value of Dapagliflozin imports from MALAYSIA to India is $64 USD, across 2 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists